Annelien Bredenoord is a professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht. Her research, consultancy and teaching is focused on the ethical issues in emerging biomedical technology and translational medicine. She is particularly fascinated by the rapid developments in genetics/genomics, regenerative medicine, stem cell research, biobanking, surgical innovation, Big Data and the associated ethical and societal challenges: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way?
She published widely in those fields and is member of several (inter)national committees among which the Ethics Committee of the International Society for Stem Cell Research (ISSCR), The Young Academy of the Royal Netherlands Academy of Arts and Sciences (KNAW), The Young Health Council, The National Indication Committee Preimplantation Genetic Diagnosis, The NIAS Lorenz Advisory Board, L 'Oreal UNESCO For Women in Science program, and UMC Utrecht’s Research Ethics Committee (METC).
Safarlou CW, Bredenoord AL, Vermeulen R, Jongsma KR.
Am J Bioeth. 2021 Dec;21(12):73-75.
The environment we live in has a dominant impact on our health. It explains an estimated seventy percent of the chronic disease burden. Where we live, what we eat, how much we exercise, the air we breathe and whom we associate with; all of these environmental factors play a role. The combination of these factors over the life course is called the exposome. There is general (scientific) consensus that understanding more about the exposome will help explain the current burden of disease and that it provides entry points for prevention and ...
Read More
